Expertise in

conditions

Dr. Drew S. Dill

Hematology Oncology | Hematology | Oncology

Baptist Memorial Medical Group Inc

1500 W Poplar Ave Ste 308,

Collierville, TN

Accepting New Patients

Referral may be required

Before you request

Expertise in

conditions

Baptist Memorial Medical Group Inc

1500 W Poplar Ave Ste 308,

Collierville, TN

Overview

Drew Dill is a Hematologist Oncology specialist and a Hematologist practicing medicine in Collierville, Tennessee.

Dr. Dill is highly rated in 55 conditions, according to our data. His clinical expertise encompasses Angiosarcoma, Inflammatory Breast Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, and Bone Marrow Aspiration.

He is actively involved in clinical research, co-authoring 1 peer reviewed article and participating in 4 clinical trials. Dr. Dill is currently accepting new patients.

Specialties

Hematology Oncology

Hematology

Oncology

Licenses

Internal Medicine in AR

Hospital Affiliations

Baptist Memorial Hospital Tipton

Methodist Hospitals Of Memphis

Baptist Memorial Hospital Desoto

Saint Francis Bartlett Medical Center

Baptist Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance

Find your insuranceClose

Accepted insurance plans:

Aetna

Anthem BCBS

Blue Cross Blue Shield

Blue Shield of California

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

CareFirst

Cigna

Devoted Health

MEDICARE MAPD
OTHER MEDICARE

Farm Bureau Health Plans

HMO
MEDICARE MAPD
MEDICARE PDP

Health Care Services Corporation

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D
PPO

Highmark

HMO Partners

Horizon Healthcare

Humana

HMO
INDEMNITY
POS
PPO

Independent Health

Magnolia Health

Managed Medicaid

OTHER MANAGED MEDICAID

Medicaid

OTHER MEDICAID
STATE MEDICAID

Medicare

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE PART D

Meridian Choice

HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER COMMERCIAL
OTHER MEDICARE
OTHER MEDICARE PART D

MetroPlus Health

INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE-MEDICAID PLAN

Oscar

Premera Blue Cross

INSURANCE PLAN
MEDICARE MAPD
OTHER COMMERCIAL
PPO

TeamCare

OTHER COMMERCIAL

UnitedHealthcare

Wellcare

EPO
HMO
INSURANCE PLAN
MANAGED MEDICAID PLAN
MEDICARE MAPD
MEDICARE PDP
MEDICARE SNP
MEDICARE-MEDICAID PLAN
OTHER MEDICARE
OTHER MEDICARE PART D

View 20 Less Insurance Carriers -

Locations

Baptist Memorial Medical Group Inc
1500 W Poplar Ave Ste 308, Collierville, TN 38017

Call: 901-861-8550

Other Locations

Office
7205 Wolf River Blvd Ste 200, Germantown,, TN 38138

Call: 901-227-8950

Additional Areas of Focus

Dr. Dill has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Dose Finding Study Followed by Phase II Randomized, Placebo-Controlled Study of Veliparib (ABT-888) Added to Chemoradiotherapy With Carboplatin and Paclitaxel for Unresectable Stage III Non-small Cell Lung Cancer (NSCLC), (NCI Study Number 8811)

Enrollment Status: Active_not_recruiting

Publish Date: August 04, 2026

Intervention Type: Other, Drug, Radiation

Study Drugs: Carboplatin, Paclitaxel, Veliparib

Study Phase: Phase 1/Phase 2

A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy

Enrollment Status: Active_not_recruiting

Publish Date: July 27, 2026

Intervention Type: Drug

Study Drugs: Capecitabine, Carboplatin, Cisplatin

Study Phase: Phase 3

(CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response

Enrollment Status: Active_not_recruiting

Publish Date: July 10, 2026

Intervention Type: Procedure, Biological, Drug, Radiation

Study Drugs: Docetaxel, Nab-Paclitaxel, Paclitaxel, Pertuzumab, Trastuzumab, Trastuzumab Emtansine

Study Phase: Phase 2

A Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil in Chemotherapy Exposed Breast Cancer Survivors With Cognitive Impairment

Enrollment Status: Completed

Publish Date: September 13, 2023

Intervention Type: Drug

Study Drug: Donepezil

Study Phase: Phase 3

View 3 Less Clinical Trials

1 Total Publications

Ruptured Appendicitis and a Palpable Mass: Delayed Presentation of Appendiceal Actinomycosis.

Journal: The American surgeon

Published: May 03, 2019

Similar Doctors

Expertise in

conditions

Dr. Raymond U. Osarogiagbon

Hematology Oncology | Hematology | Oncology

Expertise in

conditions

Dr. Raymond U. Osarogiagbon

Hematology Oncology | Hematology | Oncology

Referral may be required

Before you request

Laboratory Corporation Of America Holdings

7900 Airways Blvd Bldg B,

Southaven,, MS

(20.9 miles away)

662-349-2442

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Offers Telehealth

Raymond Osarogiagbon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Southaven,, Mississippi. Dr. Osarogiagbon is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Nodules, Lung Adenocarcinoma, and Endoscopy. Dr. Osarogiagbon is currently accepting new patients.

Expertise in

conditions

Dr. Amar J. Gajjar

Hematology | Oncology

Expertise in

conditions

Dr. Amar J. Gajjar

Hematology | Oncology

Referral may be required

St. Jude Children's Research Hospital

262 Danny Thomas Pl,

Memphis, TN

(23.2 miles away)

901-595-2615

Languages Spoken:

English

See accepted insurances

Accepting New Patients

Amar Gajjar is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Gajjar is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Posterior Fossa Tumor, Brain Tumor, Embryonal Tumor with Multilayered Rosettes, and Posterior Fossa Decompression. Dr. Gajjar is currently accepting new patients.

Expertise in

conditions

Dr. Giles W. Robinson

Hematology | Oncology

Expertise in

conditions

Dr. Giles W. Robinson

Hematology | Oncology

Referral may be required

St. Jude Children's Research Hospital

262 Danny Thomas Pl,

Memphis, TN

(23.2 miles away)

901-595-5175

Languages Spoken:

English, Spanish

See accepted insurances

Accepting New Patients

Giles Robinson is a Hematologist and an Oncologist practicing medicine in Memphis, Tennessee. Dr. Robinson is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Medulloblastoma, Embryonal Tumor with Multilayered Rosettes, Posterior Fossa Tumor, and Rhabdoid Tumor. Dr. Robinson is currently accepting new patients.

VIEW MORE Hematologist Oncologists

Frequently Asked Questions about Dr. Drew S. Dill

How do I make an appointment with Dr. Drew S. Dill?

You can book an appointment with Dr. Drew S. Dill by calling their office at 901-861-8550. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Drew S. Dill a top-rated expert for Angiosarcoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Drew S. Dill is classified as an Distinguished expert for Angiosarcoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Drew S. Dill specialize in?

While Dr. Drew S. Dill is a Hematology Oncology, they have specific expertise in Angiosarcoma, Inflammatory Breast Cancer, and Iron Deficiency Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology Oncology.

Does Dr. Drew S. Dill participate in research or clinical trials?

Yes. Dr. Drew S. Dill has published 1 articles and abstracts on conditions like Angiosarcoma. You can view a list of Dr. Drew S. Dill's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Drew S. Dill accept my insurance?

Dr. Drew S. Dill accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 901-861-8550 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dill's expertise for a condition

ConditionClose